6 questions answered from cited research · Plain language
Early animal and lab studies suggest Euonymus alatus extracts and one of its compounds may slow diabetic retinopathy by blocking abnormal blood vessel growth, but human evidence is lacking.
Read the full answer →There is no direct evidence that Ganoderma lucidum polysaccharides treat diabetic retinopathy; one review found they promote angiogenesis (new blood vessel growth), which could be a concern in retinopathy [9].
Read the full answer →Yes, smartphone-based imaging combined with AI screening tools can effectively detect diabetic retinopathy in low-resource settings, though further real-world testing is needed.
Read the full answer →Yes, a high LDL-C to HDL-C ratio (≥2.0) is linked to a higher risk of cardiovascular events in people with type 2 diabetes and diabetic retinopathy, even when taking statins.
Read the full answer →AI screening tools detect diabetic retinopathy with high accuracy, outperforming conventional methods in meta-analyses, but real-world performance varies.
Read the full answer →Current evidence shows no significant link between diabetic retinopathy and age-related macular degeneration, despite shared risk factors.
Read the full answer →